Clinical Problems Asthma 2017
DOI: 10.1183/1393003.congress-2017.pa654
|View full text |Cite
|
Sign up to set email alerts
|

Impact of mepolizumab on work productivity and activity impairment in severe eosinophilic asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Furthermore, no evidence has been seen of significant improvement in productivity in patients with uncontrolled persistent asthma treated with biologics targeting IL-5. 23 In conclusion, patients with uncontrolled persistent asthma who do not respond to currently available therapies are in need of additional treatment options. This analysis demonstrates that dupilumab every 2 weeks regimens provide significant and clinically meaningful improvements in asthma control, asthma symptoms, and QoL and significantly improve workplace productivity.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, no evidence has been seen of significant improvement in productivity in patients with uncontrolled persistent asthma treated with biologics targeting IL-5. 23 In conclusion, patients with uncontrolled persistent asthma who do not respond to currently available therapies are in need of additional treatment options. This analysis demonstrates that dupilumab every 2 weeks regimens provide significant and clinically meaningful improvements in asthma control, asthma symptoms, and QoL and significantly improve workplace productivity.…”
Section: Discussionmentioning
confidence: 99%